Upcoming Webinars
-
FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
In this webinar, Denise Holliday, Expert Witness at Capwell Consulting Group, helps you understand how the transition to QMSR may affect regulatory compliance, product liability exposure, and organizational risk.
Register for FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry Read More about FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
Past Webinars
-
Claims 2020: A Year Unlike Any Other
In this year’s annual year-end wrap-up, a panel that includes members of Medmarc’s Claims team along with David Waxman of Saul Ewing Arnstein & Lehr LLP will summarize the state of the medical...
Read More about Claims 2020: A Year Unlike Any Other -
Ripped From the Headlines: A(n Eventful) Year in Review
In this installment of Medmarc’s webinar series, Kate Klaus, an attorney and FDA specialist in our Risk Management department, will guide a discussion of the top life sciences news stories of the...
Read More about Ripped From the Headlines: A(n Eventful) Year in Review -
The Potential Life Sciences Implications of the Election
The medtech industry has significantly changed during the Trump administration’s last four years. FDA processes are streamlined, the medical device excise tax repealed, and the Senate is in the...
Read More about The Potential Life Sciences Implications of the Election -
How to Write Effective and Compliant Standard Operating Procedures (SOPs)
In this session, presenter, Joy McElroy from McElroy Training and Consultancy, will discuss the benefits of good technical writing, how to write effective and compliant SOPs using the correct...
Read More about How to Write Effective and Compliant Standard Operating Procedures (SOPs)